The Journal of Drugs in Dermatology (JDD), a full-color, peer-reviewed publication indexed with MEDLINE®/PubMed®, was founded by the renowned Dr. Perry Robins, MD. Now in its 14th year, it offers one of the fastest routes to disseminate dermatologic information, and is considered the fastest growing publication in dermatology.
We present original articles, award-winning case reports, and timely features pertaining to new methods, techniques, and drug therapy in dermatology, which provides readers with peer-reviewed content of the utmost quality.
Our high standards of content are maintained through a balanced, peer-review process. Articles are reviewed by an International Editorial Board of over 150 renowned experts.
JDD reaches around 14,500 dermatology healthcare professionals and has been recognized as the official publication of the International Society of Dermatologic Surgery (ISDS), Skin of Color Seminar Series (SOCSS), and the Orlando Dermatology Aesthetic and Clinical (ODAC) Conference.
The extremely current and practical editorial content of JDD results in high readership and maximum exposure among the dermatology community.
Our Mission is Excellence Through Peer Review: To educate physicians, optimize patient outcomes, and disseminate key scientific information.